Search Results - netaly+khazanov

1 Results Sort By:
Small Molecules for Treating Cystic Fibrosis
ApplicationSmall molecule compounds to potentiate most common type of CFTR mutation in cystic fibrosis patients.Key BenefitsPotentiates ΔF508-hCFTR mutation, addressing more than 60 percent of CF patients. Market SummaryCystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and ion channel that malfunctions in the genetic...
Published: 7/30/2024   |   Inventor(s): Nael McCarty, Guiying Cui, Hanoch Senderowitz, Netaly Khazanov
Keywords(s): Rare/Orphan Diseases, Respiratory, Small Molecule
Category(s): TechPub Algolia > Therapeutics, TechPub Algolia > Drug Discovery